Eli Lilly & Co. (LLY) – Mergers and Acquisitions
-
Lilly (LLY) Completes Acquisition of POINT Biopharma (PNT)
-
Fusion Pharmaceuticals (FUSN) is 'sole remaining clinical-stage, targeted radiopharm player,' seen as takeover target - Oppenheimer
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LLY Stock Lookup